Active, not recruitingPhase 1NCT03220022
Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas
Studying OBSOLETE: HIV-related Non-Hodgkin lymphoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Ida C Wong-SefidanAIDS Malignancy Consortium
- Intervention
- Cyclophosphamide(drug)
- Enrollment
- 46 enrolled
- Eligibility
- 18-64 years · All sexes
- Timeline
- 2018 – 2026
Study locations (19)
- UC San Diego Moores Cancer Center, La Jolla, California, United States
- UCSF Medical Center-Parnassus, San Francisco, California, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States
- Memorial Hospital West, Pembroke Pines, Florida, United States
- John H Stroger Jr Hospital of Cook County, Chicago, Illinois, United States
- University of Illinois College of Medicine - Chicago, Chicago, Illinois, United States
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States
- Boston Medical Center, Boston, Massachusetts, United States
- Siteman Cancer Center at Washington University, St Louis, Missouri, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- Mount Sinai Hospital, New York, New York, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- Montefiore Medical Center - Moses Campus, The Bronx, New York, United States
- Memorial Sloan Kettering Nassau, Uniondale, New York, United States
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
- +4 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03220022 on ClinicalTrials.govOther trials for OBSOLETE: HIV-related Non-Hodgkin lymphoma
Additional recruiting or active studies for the same condition.
See all trials for OBSOLETE: HIV-related Non-Hodgkin lymphoma →